(Q42623970)

3 November 2017

title

Exogenous granulocyte-macrophage colony-stimulating factor administration for pulmonary alveolar proteinosis (English)

1 reference

3 November 2017

1 reference

Kavuru MS

1

1 reference

3 November 2017

Sullivan EJ

2

1 reference

3 November 2017

Piccin R

3

1 reference

3 November 2017

Thomassen MJ

4

1 reference

3 November 2017

Stoller JK

5

1 reference

3 November 2017

language of work or name

English

0 references

publication date

1 April 2000

1 reference

American Journal of Respiratory and Critical Care Medicine

3 November 2017

published in

1 reference

3 November 2017

volume

161

1 reference

3 November 2017

issue

4 Pt 1

1 reference

3 November 2017

page(s)

1143-1148

1 reference

Pulmonary Alveolar Proteinosis

3 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.4.9906044

Pulmonary alveolar phospholipoproteinosis: experience with 34 cases and a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.4.9906044

Pulmonary alveolar proteinosis: clinical features and outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.4.9906044

Pulmonary Alveolar Proteinosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.4.9906044

Granulocyte/macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.4.9906044

Involvement of granulocyte-macrophage colony-stimulating factor in pulmonary homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.4.9906044

Mice deficient for the IL-3/GM-CSF/IL-5 beta c receptor exhibit lung pathology and impaired immune response, while beta IL3 receptor-deficient mice are normal

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.4.9906044

Pulmonary epithelial cell expression of GM-CSF corrects the alveolar proteinosis in GM-CSF-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.4.9906044

The pulmonary alveolar proteinosis in granulocyte macrophage colony-stimulating factor/interleukins 3/5 beta c receptor-deficient mice is reversed by bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.4.9906044

Persistence of pulmonary pathology and abnormal lung function in IL-3/GM-CSF/IL-5 beta c receptor-deficient mice despite correction of alveolar proteinosis after BMT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.4.9906044

Alveolar proteinosis: diagnosis and treatment over a 10-year period

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.4.9906044

Human pulmonary alveolar proteinosis associated with a defect in GM-CSF/IL-3/IL-5 receptor common beta chain expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.4.9906044

Idiopathic pulmonary alveolar proteinosis as an autoimmune disease with neutralizing antibody against granulocyte/macrophage colony-stimulating factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.4.9906044

10.1164/AJRCCM.161.4.9906044

21 January 2018

Identifiers

DOI

1 reference

3 November 2017

1 reference